Aclaris Therapeutics, Inc. (ACRS)
3.51
+0.89
(+33.97%)
USD |
NASDAQ |
Jan 20, 11:09
Aclaris Therapeutics Price: 3.51 for Jan. 20, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Corcept Therapeutics, Inc. | 34.15 |
| Puma Biotechnology, Inc. | 6.495 |
| Nephros, Inc. | 4.62 |
| Prelude Therapeutics, Inc. | 1.93 |
| Vivos Therapeutics, Inc. | 2.07 |
Price Related Metrics
| PS Ratio | 25.80 |
| PEG Ratio | -0.0153 |
| Price to Book Value | 3.167 |
| Earnings Yield | -39.36% |
| Market Cap | 380.29M |
| PEGY Ratio | -0.0153 |